Cargando…

Hybrid 2-[(18)F] FDG PET/MRI in premanifest Huntington’s disease gene-expansion carriers: The significance of partial volume correction

BACKGROUND: Huntington’s disease (HD) is an inherited, progressive neurodegenerative disease that has no cure. Striatal atrophy and hypometabolism has been described in HD as far as 15 years before clinical onset and therefore structural and functional imaging biomarkers are the most applied biomark...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hellem, Marie N. N., Vinther-Jensen, Tua, Anderberg, Lasse, Budtz-Jørgensen, Esben, Hjermind, Lena E., Larsen, Vibeke Andrée, Nielsen, Jørgen E., Law, Ian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195345/ https://www.ncbi.nlm.nih.gov/pubmed/34115782 http://dx.doi.org/10.1371/journal.pone.0252683

Ejemplares similares

Endophenotypical drift in Huntington’s disease: a 5-year follow-up study
por: Hellem, Marie N. N., et al.
Publicado: (2021)

A clinical classification acknowledging neuropsychiatric and cognitive impairment in Huntington’s disease
por: Vinther-Jensen, Tua, et al.
Publicado: (2014)

Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease
por: Vinther-Jensen, Tua, et al.
Publicado: (2016)

Seven-year clinical follow-up of premanifest carriers of Huntington's disease
por: Hart, Ellen, et al.
Publicado: (2011)

Magnetization transfer imaging in ‘premanifest’ Huntington’s disease
por: Jurgens, Caroline K., et al.
Publicado: (2009)

Peripheral Biomarkers in Manifest and Premanifest Huntington’s Disease
por: Morena, Emanuele, et al.
Publicado: (2023)

Sleep deficits but no metabolic deficits in premanifest Huntington's disease
por: Lazar, Alpar S., et al.
Publicado: (2015)

No optical coherence tomography changes in premanifest Huntington's disease mutation carriers far from disease onset
por: Schmid, Rahel Dominique, et al.
Publicado: (2022)

White matter predicts functional connectivity in premanifest Huntington's disease
por: McColgan, Peter, et al.
Publicado: (2017)

MRI T2 Hypointensities in basal ganglia of premanifest Huntington's disease
por: Jurgens, Caroline K, et al.
Publicado: (2010)

Premanifest Huntington’s disease: Examination of oculomotor abnormalities in clinical practice
por: Winder, Jessica Y., et al.
Publicado: (2018)

Testing a longitudinal compensation model in premanifest Huntington’s disease
por: Gregory, Sarah, et al.
Publicado: (2018)

In vivo characterization of white matter pathology in premanifest huntington's disease
por: Zhang, Jiaying, et al.
Publicado: (2018)

Computerised Dynamic Posturography in Premanifest and Manifest individuals with Huntington’s Disease
por: Reyes, Alvaro, et al.
Publicado: (2018)

Visual Object Perception in Premanifest and Early Manifest Huntington’s Disease
por: Coppen, Emma M, et al.
Publicado: (2019)

Time will tell: Decision making in premanifest and manifest Huntington’s disease
por: Heim, Beatrice, et al.
Publicado: (2020)

Abnormal Electrophysiological Motor Responses in Huntington’s Disease: Evidence of Premanifest Compensation
por: Turner, Lauren M., et al.
Publicado: (2015)

Safer Attitude to Risky Decision-Making in Premanifest Huntington’s Disease Subjects
por: D’Aurizio, Giulia, et al.
Publicado: (2019)

Revealing the Timeline of Structural MRI Changes in Premanifest to Manifest Huntington Disease
por: Wijeratne, Peter A., et al.
Publicado: (2021)

Social Cognition, Executive Functions and Self-Report of Psychological Distress in Huntington’s Disease
por: Larsen, Ida Unmack, et al.
Publicado: (2016)

Linking white matter and deep gray matter alterations in premanifest Huntington disease
por: Faria, Andreia V., et al.
Publicado: (2016)

Baseline multimodal information predicts future motor impairment in premanifest Huntington's disease
por: Castro, Eduardo, et al.
Publicado: (2018)

Structural and functional brain network correlates of depressive symptoms in premanifest Huntington's disease
por: McColgan, Peter, et al.
Publicado: (2017)

Timing of selective basal ganglia white matter loss in premanifest Huntington’s disease
por: Zeun, Paul, et al.
Publicado: (2022)

Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease
por: Stout, Julie C, et al.
Publicado: (2012)

Body composition in premanifest Huntington’s disease reveals lower bone density compared to controls.
por: Goodman, Anna O. G., et al.
Publicado: (2011)

Novel Nut and Bolt Task Quantifies Motor Deficits in Premanifest and Manifest Huntington’s Disease
por: Collins, Lucy M., et al.
Publicado: (2015)

Topological length of white matter connections predicts their rate of atrophy in premanifest Huntington’s disease
por: McColgan, Peter, et al.
Publicado: (2017)

Resting-state connectivity stratifies premanifest Huntington’s disease by longitudinal cognitive decline rate
por: Polosecki, Pablo, et al.
Publicado: (2020)

The effect of impulsivity and inhibitory control deficits in the saccadic behavior of premanifest Huntington’s disease individuals
por: Júlio, Filipa, et al.
Publicado: (2019)

Hair and salivary cortisol and their relationship with lifestyle, mood and cognitive outcomes in premanifest Huntington’s disease
por: Cruickshank, Travis, et al.
Publicado: (2021)

The relationship between non-motor features and weight-loss in the premanifest stage of Huntington’s disease
por: Khan, Wasiq, et al.
Publicado: (2021)

Spatiotemporal Gait Parameters in Adults With Premanifest and Manifest Huntington’s Disease: A Systematic Review
por: Browning, Sasha, et al.
Publicado: (2023)

A novel cognitive-neurophysiological state biomarker in premanifest Huntington's disease validated on longitudinal data
por: Beste, Christian, et al.
Publicado: (2013)

Huntington Disease: The Complexities of Making and Disclosing a Clinical Diagnosis After Premanifest Genetic Testing
por: McCusker, Elizabeth A., et al.
Publicado: (2017)

Intact sensory-motor network structure and function in far from onset premanifest Huntington’s disease
por: Gorges, Martin, et al.
Publicado: (2017)

Perceptions about Research Participation among Individuals at Risk and Individuals with Premanifest Huntington’s Disease: A Survey Conducted by the European Huntington Association
por: Júlio, Filipa, et al.
Publicado: (2021)

Investigating the relationships between hypothalamic volume and measures of circadian rhythm and habitual sleep in premanifest Huntington's disease
por: Bartlett, Danielle M., et al.
Publicado: (2018)

Multi-compartment analysis of the complex gradient-echo signal quantifies myelin breakdown in premanifest Huntington's disease
por: Casella, Chiara, et al.
Publicado: (2021)

Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study
por: Paulsen, Jane S., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_pbdgpv3mtl41bek0bf2b7k2r67